Gullberg & Jansson (”Gullberg” eller ”Bolaget”) producerar, marknadsför och distribuerar miljövänlig...
Redeye endorses CLS’ partnership with the Dutch company Soteria Medical.
Fortsatt påverkade av kostnadsinflation... Nettoomsättningen ökade 1,5% y/y till 1027 mkr (1012), me...
Q4 rapport Hansas rapport för det fjärde kvartalet var i stora drag i linje med våra förväntningar.
Redeye comments on Kontigo Cares Q4'22 report, in which Net Sales (SEK7.
Consti's net sales in Q4 amounted to EUR 93.3m, above our and consensus estimates (EUR 85.
Redeye provides its initial take on Mentice’s Q4 2022 report, which came in broadly below our estima...
Suominen’s Q4 comparable EBITDA of EUR 5m remained unchanged from previous quarter and missed consen...
Redeye sees a solid Q4 report from Addnode with strong organic and acquired growth.
Redeye argues that the second half-year report from Zwipe was largely in line with our expectations.
CapMan’s operative performance in Q4 was quite decent with the big surprise being the divestment of ...
DT delivered solid Q4 growth. EBIT came down with high cost inflation.
Redeye updates its view on Evolution post Q4-results which came in just above our expectations and w...
Redeye states that the Q4 report was good, leading to a well-deserved relief to the share price.
Redeye provides a preview ahead of Fragbite Groups Q4 report, due on 23th February, where we slightl...
Redeye comments on Spago’s Q4 2022 report, and we estimate that the company is making solid progress...
FY'22 PTP guidance DKK ~600m, at high end of the old range Strong Q4e based on 21% NII growth q-o-q ...
We expect Q4 to be on the soft side The focus will be on the leadership changes.
Q4e: EBITDA of NOK 17.9m Margins set to rise in '23e on lower e-com investments '23e adj.
Redeye endorses that NeoDynamics partners with Uniphar for US distribution and logistics.
